AURO.it INCONTINENZA URINARIA 2003

164
290. Farrar DJ, Osborne JL, Stephenson TP, Whiteside CG, Weir J, Berry J, Milroy EJG,
Turner Warwick R: A urodynamic view of bladder outflow obstruction in the
female: factors influencing the results of treatment. Br J Urol 47: 815-822, 1976.
291. Massey JA, Abrams PH: Obstructed voiding in the female. Br J Urol 61: 36-39,
1988.
292. Ramsay IN, Alì IM, Hunter M, Stark D, Donaldson K: A randomised controlled trial
of urodynamic investigations prior to conservative treatment of urinary
incontinence in the female. Int J Gynaecol Obstet 6: 277-281, 1995.
293. Iglesia CB, Shott S. Fenner DE et al: Effect of preoperative voiding mechanism on
success rate of autologous rectus fascia suburethral sling procedure. Obstet
Gynecol 91: 577, 1998.
294. Spencer JR, O’Conor VJ, Schaeffer AJ: A comparison of endoscopic suspension of
the vesical neck with suprapubic vesicourethropexy for treatment of stress urinary
incontinence. J Urol 137: 411-415, 1987.
295. Horbach NS. Suburethral sling procedures. In: Urogynecology and Urodynamics,
Theory and Practice, 3rd Edition. DR Ostergard and AE Bent (Eds) Williams and
Wilkins 1991, 413-421.
296. Wang AC. Burch colposuspension vs. Stamey bladder neck suspension. A
comparison of complications with special emphasis on detrusor instability and
voiding dysfunction. J Reprod Med 41: 529-533, 1996.
297. Zimmern PE, Hadley HR, Leach GE, Raz S. Female urethral obstruction after
Marshall-Marchetti-Krantz operation. J Urol 138: 517-521, 1987.
298. Carr LK and Webster GD: Voiding dysfunction following incontinence surgery:
diagnosis and treatment with retropubic or vaginal urethrolysis. J Urol 157: 821,
1997.
299. Grino PB, Bruskewitz R, Blaivas JG, Siroky MB et al: Maximum urinary flow rate
by uroflowmetry: Automatic or visual interpretation. J Urol 149: 339-341, 1993.
300. Abrams PH, Griffiths DJ: The assessment of prostatic obstruction from urodynamic
measurements and from residual urine . Br J Urol 51: 129-134, 1979.
301. Dunsmuir WD, Feneley M, Corry DA, Bryan J, Kirby JS: The day-to-day variation
(test-retest reliability) of residual urine measurement. Br J Urol 77: 192-193,
1996.
302. Porru D, Jallous H, Cavalli V, Sallusto F, Rovereto B: Prognostic value of a
combination of IPSS, flow rate and residual urine volume compared to pressureflow
studies in the preoperative evaluation of symptomatic BPH. Eur Urol 41:
246-249,2002.
303. Donovan JL, Kay HE, Peters TJ, Abrams P, Coast J et al.: Using the ICSQoL to
measure the impact of lower urinary tract symptoms on quality of life: Evidence
from the ICS-”BPH” study. Br J Urol 80: 712-721, 1997.
304. Barry MJ, Fowler FJ, O’Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK:
Measuring disease-specific health status in men with benign prostatic hyperplasia.
Med Care 334,: 145-155, 1995.